Fund
Longwood Fund
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 2
- Lead
- 0
- New entries
- 2
- Follow ons
- 0
- Latest operation
- 13 August 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 13 Aug | United States, Biotech | Series B | 50 M$ | Participant |
| 28 Apr | Belgium, Biotech | Series A | 125 M$ | Participant |
Co investors 11 funds crossed
- Alexandria Venture Investments 1 operation
- Balyasny Asset Management 1 operation
- Finchley Healthcare Ventures 1 operation
- Forbion 1 operation
- Forge Life Science Partners 1 operation
- Galapagos 1 operation
- Luma Group 1 operation
- Novo Holdings 1 operation
- Regeneron Ventures 1 operation
- Samsara BioCapital 1 operation
- Sofinnova Investments 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States, Belgium.